Paraskevi Morris1, Lucy Manuel2, Campbell D Flynn2,3,1, Matteo Matteucci4,5, Daniele Ronco4,5, Giulio Massimi4,6, Federica Torchio4,5, Roberto Lorusso4,7. 1. Faculty of Medicine and Health, University of Sydney, Sydney, Australia. 2. Department of Cardiothoracic Surgery, Royal North Shore Hospital, Sydney, NSW, Australia. 3. North Shore Cardiothoracic Research Institute (NCRI), Sydney, Australia. 4. Cardio-Thoracic Surgery Dept., Heart & Vascular Centre, Maastricht University Medical Centre (MUMC), Maastricht, The Netherlands. 5. Department of Cardiac Surgery, Circolo Hospital, University of Insubria, Varese, Italy. 6. Department of Cardiac Surgery, Santa Maria della Misericordia Hospital, Perugia, Italy. 7. Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.
Abstract
Background: Improvements in revascularisation, including pharmacological, catheter-based and surgical, have resulted in improved outcomes for patients with acute myocardial infarction (AMI), leading to decreased frequency of mechanical complications. Improvements in both techniques and technology have permitted select patients to be managed with a purely percutaneous, transcatheter strategy. Through systematic review, this study aims to synthesise the collective experience of percutaneous treatment of the mechanical complications of ischaemic heart disease. Methods: The search strategy queried the electronic databases PubMed, Embase and the Cochrane Central Register of Controlled Trials, from 1 January 2000 to 31 December 2020. Studies highlighting the outcomes of patients receiving percutaneous treatment of post-myocardial infarction papillary muscle rupture (PMR), ventricular septal defect (VSD), left ventricular free wall rupture (FWR) and pseudoaneurysm (PA) were included. A qualitative review of studies was conducted for PMR, FWR and PA. A quantitative analysis was conducted for VSD. Results: Fifteen studies were included in the qualitative synthesis of the percutaneous management of PMR, 4 were included in the qualitative analysis of the percutaneous management of left ventricular FWR, 7 studies defined the outcomes of the percutaneous management of PA and 25 were included in the quantitative meta-analysis of the primary percutaneous management of post-MI VSD. For VSD, there were 43 failed procedures in 314 patients. The proportion of failed procedures was 15.9% and there were 174 deaths in 428 patients. 37.5% of patients experienced early mortality. Conclusions: Although surgical techniques remain the gold standard, we have shown that percutaneous management may be a viable option in certain cases. 2022 Annals of Cardiothoracic Surgery. All rights reserved.
Background: Improvements in revascularisation, including pharmacological, catheter-based and surgical, have resulted in improved outcomes for patients with acute myocardial infarction (AMI), leading to decreased frequency of mechanical complications. Improvements in both techniques and technology have permitted select patients to be managed with a purely percutaneous, transcatheter strategy. Through systematic review, this study aims to synthesise the collective experience of percutaneous treatment of the mechanical complications of ischaemic heart disease. Methods: The search strategy queried the electronic databases PubMed, Embase and the Cochrane Central Register of Controlled Trials, from 1 January 2000 to 31 December 2020. Studies highlighting the outcomes of patients receiving percutaneous treatment of post-myocardial infarction papillary muscle rupture (PMR), ventricular septal defect (VSD), left ventricular free wall rupture (FWR) and pseudoaneurysm (PA) were included. A qualitative review of studies was conducted for PMR, FWR and PA. A quantitative analysis was conducted for VSD. Results: Fifteen studies were included in the qualitative synthesis of the percutaneous management of PMR, 4 were included in the qualitative analysis of the percutaneous management of left ventricular FWR, 7 studies defined the outcomes of the percutaneous management of PA and 25 were included in the quantitative meta-analysis of the primary percutaneous management of post-MI VSD. For VSD, there were 43 failed procedures in 314 patients. The proportion of failed procedures was 15.9% and there were 174 deaths in 428 patients. 37.5% of patients experienced early mortality. Conclusions: Although surgical techniques remain the gold standard, we have shown that percutaneous management may be a viable option in certain cases. 2022 Annals of Cardiothoracic Surgery. All rights reserved.
Authors: Miguel Rodríguez-Santamarta; Rodrigo Estévez-Loureiro; Javier Gualis; David Alonso; Armando Pérez de Prado; Felipe Fernández-Vázquez Journal: Rev Esp Cardiol (Engl Ed) Date: 2015-01-20
Authors: George J Arnaoutakis; Yue Zhao; Timothy J George; Christopher M Sciortino; Patrick M McCarthy; John V Conte Journal: Ann Thorac Surg Date: 2012-05-23 Impact factor: 4.330
Authors: Muhammad Yasin; Aravinda Nanjundappa; Frank H Annie; Alfred Tager; Ali Farooq; Abhishek Bhagat; Vallabh Karpe Journal: Cureus Date: 2018-07-30